Provided by Tiger Fintech (Singapore) Pte. Ltd.

Co-diagnostics Inc.

0.5209
-0.0391-6.98%
Volume:15.66K
Turnover:8.50K
Market Cap:16.63M
PE:-0.38
High:0.5600
Open:0.5550
Low:0.5208
Close:0.5600
Loading ...

Co-Diagnostics Inc expected to post a loss of 34 cents a share - Earnings Preview

Reuters
·
3 hours ago

Co-Diagnostics wins dismissal of class action lawsuit

TIPRANKS
·
07 Mar

Co-Diagnostics, Inc. Wins Dismissal of Class Action Lawsuit

PR Newswire
·
07 Mar

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025

PR Newswire
·
03 Mar

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version

Benzinga
·
24 Feb

BRIEF-Co-Diagnostics Announces Intention To Submit Enhanced Version Of Covid-19 Test To FDA

Reuters
·
22 Feb

Co-Diagnostics Plans to Seek FDA Clearance for Enhanced Version of COVID-19 Test

MT Newswires Live
·
22 Feb

Co-Diagnostics Withdraws FDA Application for Covid Test

Dow Jones
·
22 Feb

Co-Diagnostics withdraws 510k application to FDA for Co-Dx PCR COVID-19 Test

TIPRANKS
·
22 Feb

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of Covid-19 Test to FDA for 510(K) Clearance

THOMSON REUTERS
·
22 Feb

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

PR Newswire
·
22 Feb

Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill

PR Newswire
·
30 Jan

Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025

PR Newswire
·
07 Jan

Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility

PR Newswire
·
10 Dec 2024

Co-Diagnostics Price Target Maintained With a $1.50/Share by HC Wainwright & Co.

Dow Jones
·
11 Nov 2024

Co-Diagnostics Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
10 Nov 2024